Select Specialty Hospital - Orlando Inc is categorized under Hospitals in Orlando, FL and active since 2002.
Select Specialty Hospital - Orlando Inc was established in 2002, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 622110 by the NAICS.
If you are seeking more information, feel free to contact Robert Ortenzio at the company’s single location by writing to 2250 Bedford Road, Orlando, Florida FL 32803 or by phoning (407) 303-7869. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Select Specialty Hospital - Orlando Inc |
| Contact Person: | Robert Ortenzio |
| Address: | 2250 Bedford Road, Orlando, Florida 32803 |
| Phone Number: | (407) 303-7869 |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Founded: | 2002 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hospitals |
| SIC Code: | 8062 |
| NAICS Code: | 622110 |
| Share This Business: |
Select Specialty Hospital - Orlando Inc was started in 2002 to provide professional Hospitals under the SIC code 8062 and NAICS code 622110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact Robert Ortenzio for inquiries that concern Select Specialty Hospital - Orlando Inc by calling the company number (407) 303-7869, as your correspondence is most welcome. Additionally, the physical location of the single location of Select Specialty Hospital - Orlando Inc can be found at the coordinates 28.571879,-81.370375 as well as the street address 2250 Bedford Road in Orlando, Florida 32803.
For its online presence, you may visit Select Specialty Hospital - Orlando Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.